Home
About CQCO
Signature Events
Awards
Program Reviews
Publications
Quality Index
Cancer in Ontario
Comparisons
By Patient Journey
By Type of Cancer
By Quality Dimension
Indicators by LHIN
All Indicators
Cancer System Quality Index (CSQI) 2013
Safe
Fair, but more work needs to be done. Some processes for a safe cancer system are in place, and action is under way to address concerns. Better system measures are needed to understand complications of care, across all aspects of cancer treatment and from the patient’s perspective.
Unplanned Visits to Hospital after Adjuvant Chemotherapy
Systemic Treatment Safety: Best Practice Drug Ordering
Modifiable Risk Factors
(alcohol consumption; obesity; physical inactivity; sedentary activities; inadequate vegetable and fruit consumption; tobacco use - current smoking, second-hand smoke, teen risk)
Breast Cancer Screening: Follow-up of Abnormal Results
Cervical Cancer Screening: Follow-Up of Abnormal Results
Colorectal Cancer Screening: Follow-up of Abnormal Results
Synoptic Pathology Reporting
Reporting of Cancer Stage at Diagnosis
Quality of Pathology & Cancer Surgery: Margin Status in Prostate Cancer Surgery and Rectal Cancer Surgery
Team Oriented Care for the Patient: Multidisciplinary Cancer Conferences
Treating NSC Lung Cancer According to Guidelines
Treating Stage III Colon Cancer According to Guidelines
Consultation with a Medical Oncologist
Radiation Treatment Utilization
Intensity Modulated Radiation Therapy (IMRT) Utilization
Survivorship
End-of-Life Care
(referrals for CCAC; median time between CCAC referral and death)
Breast Cancer Screening (Mammography) Participation
Cervical Cancer Screening (Pap Test) Participation
Colorectal Cancer Screening Participation (FOBT, Flexible Sigmoidoscopy, Colonoscopy)
PET/CT Utilization and Wait Times
Wait Times for Cancer Surgery
Wait Times for Radiation Treatment
Wait Times for Systemic Treatment (Chemotherapy)
Cancer Screening Retention Rates
Patient Experience with Diagnostic Assessment Programs
Patient Experience with Outpatient Cancer Care
Symptom Assessment and Management
Modifiable Risk Factors (by sociodemographic factors)
Breast Cancer Screening: Follow-Up of Abnormal Results (by socioeconomic status)
Cervical Cancer Screening: Follow-Up of Abnormal Results (by socioeconomic status)
Colorectal Cancer Screening: Follow-Up of Abnormal Results (by socioeconomic status)
Breast Cancer Screening Participation (mammography by socioeconomic status)
Cervical Cancer Screening Participation (Pap test by socioeconomic status)
Colorectal Cancer Screening Participation (FOBT, flexible sigmoidoscopy, colonoscopy, by socioeconomic status)
Cancer Screening Retention Rates (by socioeconomic status)
Cancer Screening: Integrated Participation (by socioeconomic status)
PET/CT Utilization and Wait Times (locations by geography – see map)
Patient Experience with Diagnostic Assessment Programs (locations by geography – see map)
Treating NSC Lung Cancer According to Guidelines (by sex, age, income)
Treating Stage III Colon Cancer According to Guidelines (by sex, age, income)
Consultation with a Medical Oncologist (by age)
Symptom Assessment and Management (by sex, urban/rural, income)
Survivorship (by age)
End-of-Life Care (ED and ICU visits, by income)
Cancer Screening: Integrated Participation
Primary Care and Cancer Screening
Wait Times from Diagnosis to Adjuvant Chemotherapy
Wait Times from Surgery to Adjuvant Chemotherapy
Radiation Equipment Utilization (machine efficiency; utilization and cost effectiveness of IMRT vs. non-IMRT)
Survivorship (routine follow-up visits)
End-of-Life Care
Effective
Very good. Cancer services are generally effective and evidence based, and more Ontarians are receiving treatment based on the best available evidence. Continued effort is required to achieve targets and consistency across regions.
Accessible
Very good. More Ontarians are accessing the services they need despite increases in demand. A focus on patient-centred waits is required.
Responsive
Good, but the cancer system requires more focus on patients’ and survivors’ quality of life, and consideration of the whole person and family, both during and after active treatment.
Equitable
Poor. Cancer burden is still higher among those with lower socioeconomic status. Some variation exists in the use of guidelines for patients over 70 years old. More work needs to be done, using a whole-of-society approach to ensure equity.
Integrated
Poor. Services across the system need to be coordinated to support seamless and effective patient transitions regardless of location or provider.
Efficient
Fair. Better measures are needed to determine value for money for all services, while maintaining good health outcomes and seamless patient care. Use of acute care hospital services at the end of life remains high, suggesting patients and families may not have adequate access to appropriate resources and supports.
*
Very Good
Good
Fair
Poor
Incomplete Data
*
These symbols provide an overall assessment of cancer system performance for each dimension of quality. They include at an aggregate level, an assessment of performance over time, performance against annual programmatic targets, jurisdictional comparisons and/or clinical aims for those measures available in the index. Breadth and depth of indicators across the patient continuum and type of indicator are taken into account in the assessment.
A Circle of Care needs to be developed so that all community partners who will participate with these patients connect and communicate for a seamless delivery of service.
Sandra K.
Patient and Family Advisory Council member
Special Focus
Prostate Cancer in Ontario:
A first look
CSQI 2013 Launch:
Strengthening Integration
View the webcast video of our May, 15 2013 launch
Ontario's 9th annual update on the performance of the cancer system
The first of its kind in North America, the CSQI:
Tracks Ontario’s progress against cancer
Shows where quality and performance improvements are needed
Reports on 32 evidence-based quality measures covering every aspect of cancer control, from cancer prevention to survivorship and end-of-life care
45%
of breast cancer patients went to emergency or hospital after adjuvant chemo in 2011
42%
of colon cancer patients went to emergency or hospital after adjuvant chemo in 2011
80%
of chemo visits were supported by Computerized Prescriber Order Entry in 2011
32,000 patients
were discussed at Multidisciplinary Cancer Conferences in 2012
1.1 million
Ontario women aged 50–74 were screened for breast cancer in 2010–2011
81%
of cancer surgeries were completed within the target wait time in 2012
In 2012
72% of patients accessing Diagnostic Assessment Programs got help with anxiety/fear while having hospital tests
98%
of outpatients expressed a high degree of satisfaction with their care in 2012
2.6 million
people were up-to-date with recommended cancer screening tests in 2011
43%
of cancer patients visit emergency in the last 2 weeks of life
Home
|
Media
|
Contact Us
|
Site Map
|
Terms & Conditions